Pharmacotherapy and Intensive Treatment of Drug Abuse - 1
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00000217 |
Recruitment Status :
Completed
First Posted : September 21, 1999
Last Update Posted : April 16, 2015
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Cocaine-Related Disorders Substance-Related Disorders | Drug: Carbamazepine | Phase 2 |
Study Type : | Interventional (Clinical Trial) |
Primary Purpose: | Treatment |
Official Title: | Pharmacotherapy and Intensive Treatment of Drug Abuse |
Study Start Date : | September 1990 |
Actual Primary Completion Date : | October 1996 |

- Drug use
- Effectiveness of medication
- Level of pharm
- Retention
- Depression, anxiety

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 60 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00000217
United States, Missouri | |
University of Kansas | |
Kansas City, Missouri, United States, 64128 |
Principal Investigator: | William Haning, M.D. | University of Kansas |
Responsible Party: | University of Kansas |
ClinicalTrials.gov Identifier: | NCT00000217 |
Other Study ID Numbers: |
NIDA-06954-1 R18DA006954 ( U.S. NIH Grant/Contract ) R18-06954-1 |
First Posted: | September 21, 1999 Key Record Dates |
Last Update Posted: | April 16, 2015 |
Last Verified: | April 2015 |
drug abuse |
Disease Substance-Related Disorders Cocaine-Related Disorders Pathologic Processes Chemically-Induced Disorders Mental Disorders Carbamazepine Anticonvulsants Antimanic Agents Tranquilizing Agents Central Nervous System Depressants |
Physiological Effects of Drugs Psychotropic Drugs Analgesics, Non-Narcotic Analgesics Sensory System Agents Peripheral Nervous System Agents Sodium Channel Blockers Membrane Transport Modulators Molecular Mechanisms of Pharmacological Action Cytochrome P-450 CYP3A Inducers Cytochrome P-450 Enzyme Inducers |